We are live on ! Find out more
INO icon

Inovio Pharmaceuticals
INO

212 hedge funds and large institutions have $723M invested in Inovio Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 88 increasing their positions, 48 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more repeat investments, than reductions

Existing positions increased: 88 | Existing positions reduced: 48

13% more call options, than puts

Call options by funds: $117M | Put options by funds: $104M

0.12% more ownership

Funds ownership: 2.98% → 3.1% (+0.12%)

1% less funds holding

Funds holding: 214 → 212 (-2)

4% less first-time investments, than exits

New positions opened: 48 | Existing positions closed: 50

53% less capital invested

Capital invested by funds: $1.52B → $723M (-$801M)

Holders
212
Holders Change
-2
Holders Change %
-0.93%
% of All Funds
4.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
48
Increased
88
Reduced
48
Closed
50
Calls
$117M
Puts
$104M
Net Calls
+$13.2M
Net Calls Change
-$26.5M

Top Buyers

Rank Fund Capital Flow
1
Norges Bank
Norges Bank
Norway
+$24.8M
2
WA
Wasatch Advisors
Utah
+$22M
3
State Street
State Street
Massachusetts
+$16.2M
4
Bank of America
Bank of America
North Carolina
+$15.4M
5
Coatue Management
Coatue Management
New York
+$14.4M

Top Sellers

Rank Fund Capital Flow
1
AIM
ARK Investment Management
Florida
-$20.8M
2
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
-$16M
3
NAMA
Nikko Asset Management Americas
New York
-$13.9M
4
Jane Street
Jane Street
New York
-$8.54M
5
TCM
Tekla Capital Management
Massachusetts
-$5.45M
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
26
Credit Suisse
Switzerland
$3.41M -$307K -1,470 -6%
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$3.3M -$2.53M -12,111 -34%
Man Group
28
Man Group
United Kingdom
$3.28M -$1.85M -8,887 -27%
BNP Paribas Financial Markets
29
BNP Paribas Financial Markets
France
$2.92M +$4.08M +19,556 +1,349%
Barclays
30
Barclays
United Kingdom
$2.89M -$196K -941 -4%
SC
31
Sculptor Capital
New York
$2.78M -$1.19M -5,717 -22%
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$2.75M +$354K +1,697 +9%
State of Wisconsin Investment Board
33
State of Wisconsin Investment Board
Wisconsin
$2.68M – – –
Osaic Holdings
34
Osaic Holdings
Arizona
$2.59M +$1.43M +6,844 +61%
AllianceBernstein
35
AllianceBernstein
Tennessee
$2.49M -$784K -3,761 -17%
Rafferty Asset Management
36
Rafferty Asset Management
New York
$2.28M +$2.15M +10,292 +168%
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$2.26M -$573K -2,746 -14%
PAMU
38
Pictet Asset Management (UK)
United Kingdom
$2.23M +$354K +1,700 +12%
UBS AM
39
UBS AM
Illinois
$2.22M +$786K +3,768 +31%
State of New Jersey Common Pension Fund D
40
State of New Jersey Common Pension Fund D
New Jersey
$2.21M +$885K +4,246 +36%
BCM
41
Bayesian Capital Management
New York
$1.99M +$2.97M +14,267 New
New York State Common Retirement Fund
42
New York State Common Retirement Fund
New York
$1.65M +$176K +842 +8%
GC
43
Guggenheim Capital
Illinois
$1.53M +$2.3M +11,012 New
PPA
44
Parametric Portfolio Associates
Washington
$1.5M -$449K -2,153 -17%
SM
45
Sabby Management
Florida
$1.45M +$2.14M +10,240 +6,132%
DC
46
Defender Capital
North Carolina
$1.39M +$1.38M +6,639 +198%
AQR Capital Management
47
AQR Capital Management
Connecticut
$1.34M +$886K +4,248 +79%
Deutsche Bank
48
Deutsche Bank
Germany
$1.22M +$234K +1,124 +15%
EMG
49
ETF Managers Group
New Jersey
$1.21M +$783K +3,753 +73%
MSU
50
Mizuho Securities USA
New York
$1.16M +$1.74M +8,333 New
1
2
3 4 5

INO Hedge Fund Activity: Q3 2020 in Review

212 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Inovio Pharmaceuticals (INO) for Q3 2020, worth a combined $723M — down 53% from $1.52B a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of INO and 48 opened new positions — a net loss of 2 holders — while 48 trimmed existing stakes and 88 added.

The largest buyer was Norges Bank, opening a new position worth an estimated $24.8M. The largest seller was ARK Investment Management, exiting entirely with an estimated $20.8M sold.

  • 212 institutional investors held Inovio Pharmaceuticals (INO) as of Q3 2020, down from 214 in Q2 2020.
  • Funds reported $723M of Inovio Pharmaceuticals stock for Q3 2020, down 53% quarter-over-quarter.
  • 48 funds opened new Inovio Pharmaceuticals positions in Q3 2020 and 50 closed out, a net change of -2 holders.
  • The largest Inovio Pharmaceuticals buyer in Q3 2020 was Norges Bank, an estimated $24.8M added.
  • The largest Inovio Pharmaceuticals seller in Q3 2020 was ARK Investment Management, an estimated $20.8M sold.

Based on aggregated 13F filings for Q3 2020.